Changes in thyroid cancer incidence, post-2009 American Thyroid Association guidelines

Laryngoscope

Volumn 127, Issue 10, 2017, Pages 2437-2441

  Shi, Lucy L ^a   DeSantis, Carol ^b   Jemal, Ahmedin ^b   Chen, Amy Y ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

Author keywords

guidelines; incidence rate; Thyroid cancer

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; DIFFERENTIATED THYROID CANCER; FEMALE; GENDER; HUMAN; MALE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; THYROID CANCER; TUMOR VOLUME; CLINICAL TRIAL; DIAGNOSTIC IMAGING; ECHOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; INCIDENCE; MULTICENTER STUDY; REGISTER; RETROSPECTIVE STUDY; THYROID GLAND; THYROID NEOPLASMS; UNITED STATES;

BIOPSY, FINE-NEEDLE; FEMALE; HUMANS; INCIDENCE; MALE; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RETROSPECTIVE STUDIES; SEER PROGRAM; SOCIETIES, MEDICAL; THYROID GLAND; THYROID NEOPLASMS; ULTRASONOGRAPHY; UNITED STATES;

EID: 85028659177     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.26473     Document Type: Article

References (27)

1. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 2009;115:3801–3807.
2. Kohler BA, Sherman RL, Howlader N, et al. Annual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst 2015;107:djv048.
3. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010;102:605–613.
4. O'Grady TJ, Gates MA, Boscoe FP. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981–2011. Int J Cancer 2015;137:2664–2673.
5. Davies L, Morris LG, Haymart M, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Disease state clinical review: the increasing incidence of thyroid cancer. Endocr Pract 2015;21:686–696.
6. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 2006;295:2164–2167.
7. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid: a normal finding in Finland. A systematic autopsy study. Cancer 1985;56:531–538.
8. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch Int Med 1994;154:1838–1840.
9. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer “epidemic” - screening and overdiagnosis. N Engl J Med 2014;371:1765–1767.
10. Herget KA, Patel DP, Hanson HA, Sweeney C, Lowrance WT. Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score. Cancer Med 2016;5:136–141.
11. Jemal A, Fedewa SA, Ma J, et al. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA 2015;314:2054–2061.
12. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109–142.
13. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167–1214.
14. Banerjee M, Wiebel JL, Guo C, Gay B, Haymart MR. Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence. BMJ 2016;354:i3839.
15. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 2002;94:1537–1545.
16. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, 6th Edition. New York, NY: Springer-Verlag; 2002.
17. Surveillance Research Program National Cancer Institute. SEER*Stat Software. Version 8.2.1. Bethesda, MD: National Cancer Institute; 2015.
18. Bureau UC. Table S0201 Selected Population Profile in the United States, 2014 American Community Survey 1–2. Survey 1-year estimate.
19. Smailyte G, Miseikyte-Kaubriene E, Kurtinaitis J. Increasing thyroid cancer incidence in Lithuania in 1978–2003. BMC Cancer 2006;6:284.
20. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 2014;140:317–322.
21. Hall SF, Irish J, Groome P, Griffiths R. Access, excess, and overdiagnosis: the case for thyroid cancer. Cancer Med 2014;3:154–161.
22. Machens A, Hauptmann S, Dralle H. Disparities between male and female patients with thyroid cancers: sex difference or gender divide? Clin Endocrinol (Oxf) 2006;65:500–505.
23. Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2016;2:1023–1029.
24. Ogilvie JB, Patel KN, Heller KS. Impact of the 2009 American Thyroid Association guidelines on the choice of operation for well-differentiated thyroid microcarcinomas. Surgery 2010;148:1222–1226; discussion 1226–1227.
25. Kim HG, Moon HJ, Kwak JY, Kim EK. Diagnostic accuracy of the ultrasonographic features for subcentimeter thyroid nodules suggested by the revised American Thyroid Association guidelines. Thyroid 2013;23:1583–1589.
26. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.
27. Yip L, Wharry LI, Armstrong MJ, et al. A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy. Ann Surg 2014;260:163–168.